Detalhe da pesquisa
1.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
N Engl J Med
; 390(7): 589-600, 2024 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-38354138
2.
Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria.
Malar J
; 22(1): 2, 2023 Jan 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36597076
3.
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria.
Malar J
; 20(1): 222, 2021 May 19.
Artigo
Inglês
| MEDLINE | ID: mdl-34011358
4.
A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis.
Ann Rheum Dis
; 79(12): 1600-1607, 2020 12.
Artigo
Inglês
| MEDLINE | ID: mdl-32963047
5.
SAR156597 in idiopathic pulmonary fibrosis: a phase 2 placebo-controlled study (DRI11772).
Eur Respir J
; 52(6)2018 12.
Artigo
Inglês
| MEDLINE | ID: mdl-30337444
6.
The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: design and methods.
Aging Clin Exp Res
; 29(1): 89-100, 2017 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-28144914
7.
Multicomponent intervention to prevent mobility disability in frail older adults: randomised controlled trial (SPRINTT project).
BMJ
; 377: e068788, 2022 05 11.
Artigo
Inglês
| MEDLINE | ID: mdl-35545258
8.
The "Sarcopenia and Physical fRailty IN older people: multi-componenT Treatment strategies" (SPRINTT) randomized controlled trial: Case finding, screening and characteristics of eligible participants.
Exp Gerontol
; 113: 48-57, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30261246